Teladoc Health, Inc. TDOC
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -0.30% | -1.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.30% | -1.13% | |||
| Cost of Revenue | -0.30% | -3.39% | |||
| Gross Profit | -0.30% | -0.06% | |||
| SG&A Expenses | -5.34% | -2.65% | |||
| Depreciation & Amortization | -0.48% | -1.49% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.21% | -3.19% | |||
| Operating Income | 35.85% | 29.20% | |||
| Income Before Tax | 30.68% | 37.69% | |||
| Income Tax Expenses | -34.30% | -66.71% | |||
| Earnings from Continuing Operations | 30.78% | 39.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 30.78% | 39.05% | |||
| EBIT | 35.85% | 29.20% | |||
| EBITDA | 60.48% | 259.80% | |||
| EPS Basic | 31.08% | 39.70% | |||
| Normalized Basic EPS | 42.74% | 26.92% | |||
| EPS Diluted | 31.08% | 39.70% | |||
| Normalized Diluted EPS | 42.74% | 26.92% | |||
| Average Basic Shares Outstanding | 0.47% | 1.06% | |||
| Average Diluted Shares Outstanding | 0.47% | 1.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||